Survival rate of esophageal carcinoma in iran-a systematic review and meta-analysis

Iranian Journal of Cancer Prevention

Volumn 7, Issue 2, 2014, Pages 61-65

  Yarhusseini, Amir ^a   Sharifzadeh, Loghman ^a   Delpisheh, Ali ^a   Veisani, Yousef ^a   Sayehmiri, Fatemeh ^a   Sayehmiri, Kourosh ^a  

^a ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Esophageal Neoplasm; Meta analysis; Survival rate; Systematic review

Indexed keywords

CANCER SURVIVAL; ESOPHAGUS CARCINOMA; GEOGRAPHY; HUMAN; IRAN; REVIEW; SURVIVAL RATE; SYSTEMATIC REVIEW;

EID: 84902171376     PISSN: 20082401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Parkin D, Laara E, Muir C. estimates of the world-wide frequency of sixteen major cancer in1980. int j cancer. 1988; 41(2):97-184.
2. Stathopoulos G, Tsiaras N. Epidemiology and pathogenesis of esophageal cancer: management and its controversial results review. Oncol Rep. 2003; 10(2):449-57.
3. Hormozdiari H, Day N, Aramesh B, Mahboubi E. dietryfactors and esophageal cancer in the Caspian littoral of iran. cancer research. 1975;35(3493-34).
4. Terry MS, Candet MM, Cammon MD. The Epidemiology Gastric Cancer, Carcinoma Radiationoncol 2002; 111-27.
5. Hajian K, Sedaqhat S, Sadeghi F. 5-year survival kate in patients whithesophagealcancer referred to shahidrajaiirad: therapycenter in babolsar; 1992-97. (Persian) J babol university of medical sciences. 2001; 99(3):21-8.
6. Mohagheghi MA., Musavi Jarahi A, Shariat Torbaghan S, Zeraati H. Annual report of Tehran university of medical sciences district cancer registry 1997. The cancer institute publication. 1998.
7. Azizi F, Janghorbani M, Hatami H. Epidemiology and Control of Common Disorders in Iran. 3, editor. Tehran: Khosrovi; 2010.
8. Vaziri M, Hashmi S, Pazoki A, Zahdishoolami L. Assessment of pulmonary coplications following transhiatalesophagectomy in 122 patients. iran surgery journal. 2007; 16(1):66-71.
9. Alexiou C, Khan OA, Black E, Field ML, Onyeaka P, Beggs L, et al. Survival after esophageal resection for carcinoma: The importance of the histologic cell type. Ann Thorac Surg 2006; 82(3):1073-7.
10. Hajian-Tilaki KO. Factors affecting the survival of patients with oesophageal carcinoma under radiotherapy in the north of Iran. Br J Cancer. 2001; 85(11):1671-4.
11. Agrawal D, Meekison L, Walker WS. Long-term clinical results of thoracoscopic Heller's myotomy in the treatment of achalasia. Eur J Cardiothorac Surg. 2008; 34(2):423-6.
12. Bashash M, Yavari P, Hislop TG, Shah A, Sadjadi A, Babaei M, et al. Comparison of two diverse populations, British Columbia, Canada, and Ardabil, Iran, indicates several variables associated with gastric and esophageal cancer survival. J Gastrointest Cancer. 2011; 42(1):40-5.
13. Scarpa M, Valente S, Alfieri R, Cagol M, Diamantis G, Ancona E, et al. Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World J Gastroenterol. 2011; 17(42):4660-74.
14. Tamura T, Kuwahara A, Yamamori M, Nishiguchi K, Nakamura T, Okuno T, et al. VEGF634-C/G Genotype is Predictive of Long-term Survival after Treatment with a Definitive 5-Fluorouracil/cisplatin-based Chemoradiotherapy in Japanese Patients with Esophageal Squamous Cell Carcinoma. Int J Med Sci. 2012; 9(10):833-7.
15. Blackmon SH, Correa AM, Skoracki R, Chevray PM, Kim MP, Mehran RJ, et al. Supercharged pedicledjejunal interposition for esophageal replacement: a 10-year experience. Ann Thorac Surg. 2012; 94(4):1104-11.